James M Daly Bellicum Pharmaceuticals, Inc (BLCM) insider trading activity

BLCM Quotes by TradingView

James M Daly is Director of BELLICUM PHARMACEUTICALS, INC. Currently has a direct ownership of 109,873 shares of BLCM, which is worth approximately $0. The most recent transaction as insider was on Jan 03, 2023, when has been sold 60,414 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 110K
0% 3M change
0% 12M change
Total Value Held $0

James M Daly Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2023
BUY
Exercise of conversion of derivative security
-
60,414 Added 35.48%
109,873 Common Stock
Sep 01 2022
BUY
Exercise of conversion of derivative security
-
35,082 Added 41.5%
49,459 Common Stock
Jan 04 2022
BUY
Exercise of conversion of derivative security
-
14,377 Added 50.0%
14,377 Common Stock

Also insider at

HALO
HALOZYME THERAPEUTICS, INC. Healthcare
MDGL
MADRIGAL PHARMACEUTICALS, INC. Healthcare
ACAD
ACADIA PHARMACEUTICALS INC Healthcare
JMD

James M Daly

Director
Houston, TX

Track Institutional and Insider Activities on BLCM

Follow BELLICUM PHARMACEUTICALS, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLCM shares.

Notify only if

Insider Trading

Get notified when an Bellicum Pharmaceuticals, Inc insider buys or sells BLCM shares.

Notify only if

News

Receive news related to BELLICUM PHARMACEUTICALS, INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BLCM